TECH Shareholders Approve Merger Agreement with Merck KGaA on September 23
· The NYC Memo
Bio-Techne Corporation shareholders approved the Merger Agreement Proposal related to the acquisition by Merck KGaA, Darmstadt, Germany, at a special meeting on September 23, 2026. The proposal received 121,929,544 votes for, 1,208,817 against, and 30,610 abstaining. Shareholders did not approve the Non-Binding Compensation Advisory Proposal.